Results 121 to 130 of about 68,566 (325)
Mixed QCD-electroweak corrections to Higgs boson production in gluon fusion [PDF]
, 2009 We compute the 3-loop O(\alpha \alpha_s) correction to the Higgs boson production cross section arising from light quarks using an effective theory approach. Our calculation probes the factorization of QCD and electroweak perturbative corrections to this
Anastasiou, Charalampos +2 more
core +1 more source
Biotechnology and Applied Biochemistry, EarlyView.ABSTRACT Senkyunolide I (Sen I) has a protective effect on the blood–brain barrier (BBB) in rats with sepsis‐associated encephalopathy (SAE). This study investigated whether Sen I regulates Nrf2 to ameliorate sepsis‐induced brain dysfunction (SIBD). Sixty rats were randomly assigned into Sham group, SAE group (Model group), SAE + Sen I group (72 mg/kg,
Haohao Cao, Tao Liu, Meixia Xu
wiley +1 more source
Complement C1q as a Potential Biomarker for Obesity and Metabolic Syndrome in Chinese Adolescents
Frontiers in Endocrinology, 2020 BackgroundComplement C1q (C1q) has been confirmed to be related to obesity, metabolic syndrome (MetS), and its components. However, human data regarding the associations are relatively scarce.
Xuelian Yang +4 more
doaj +1 more source
Frontiers in Immunology, 2019 C1q is the first subcomponent of the classical pathway of the complement system and belongs to the C1q/Tumor Necrosis Factor superfamily. C1q can perform a diverse range of immune and non-immune functions in a complement-dependent as well as -independent
A. Mangogna +10 more
semanticscholar +1 more source
Cooperation of C1q Receptors and Integrins in C1q-Mediated Endothelial Cell Adhesion and Spreading [PDF]
The Journal of Immunology, 2002 Abstract The interaction of C1q with endothelial cells elicits a multiplicity of biologic responses. Although these responses are presumed to be mediated by the interaction of C1q with endothelial cell surface proteins, the identity of the participants is not known.
Ellinor I.B. Peerschke +3 more
openaire +3 more sources
Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis [PDF]
, 2017 Background. In systemic lupus erythematosus patients, a strong association between the occurrence of antibodies against complement C1q (anti-C1q) and lupus nephritis can be observed.
Bigler, Cornelia +5 more
core
A central role for C1q/TNF-related protein 13 (CTRP13) in modulating food intake and body weight. [PDF]
, 2013 C1q/TNF-related protein 13 (CTRP13), a hormone secreted by adipose tissue (adipokines), helps regulate glucose metabolism in peripheral tissues. We previously reported that CTRP13 expression is increased in obese and hyperphagic leptin-deficient mice ...
Byerly, Mardi S +5 more
core +2 more sources
Biotechnology and Bioengineering, EarlyView.ABSTRACT The rise in cancer, autoimmune, inflammatory, and infectious diseases in recent decades has led to a surge in the development of monoclonal antibodies (mAbs) therapies, now the most widely used family of biologics. To meet the growing global demand, biopharmaceutical industries are intensifying their production processes.
Ilona Metayer +7 more
wiley +1 more source
Frontiers in ImmunologyLack of complement factor C1q of the classical pathway results in severely impaired primary antibody responses. This is a paradox because antibodies, especially IgM, are the most efficient activators of the classical pathway and very little specific IgM ...
Anna-Karin E. Palm +3 more
doaj +1 more source
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis [PDF]
, 2017 Background. Anti-C1q antibodies (anti-C1q) have been shown to correlate positively with systemic lupus erythematosus (SLE) nephritis. Several clinical studies indicated a high negative predictive value, suggesting that active lupus nephritis is rarely ...
Frémeaux-Bacchi, Véronique +12 more
core